Abstract:Advances in stent technology and the design of endovascular devices with thinner struts, anti‐inflammatory and antithrombotic polymers, and better drug kinetics have enhanced the safety and efficacy of the second‐generation drug‐eluting stents and broadened their use in the therapy of high‐risk patients and complex anatomies. However, despite these developments, in‐stent restenosis and stent thrombosis remain the Achilles' heel of percutaneous coronary intervention, with their cumulative incidence reaching up to 10% at 5 years following percutaneous coronary intervention. The treatment of stent failure poses challenges and is associated with a worse prognosis than conventional percutaneous coronary intervention. Several studies have recently highlighted the value of intravascular imaging in identifying causes of stent failure, underscored its role in treatment planning, and registries have shown that its use may be associated with better clinical outcomes. The present review aims to summarize the evidence in the field; it discusses the value of intravascular imaging in identifying the mechanisms of in‐stent restenosis and stent thrombosis in assessing the morphological characteristics of neointima tissue that appears to determine long‐term outcomes in evaluating procedural results, and presents the findings of studies supporting its value in guiding therapy in stent failure. Nonstandard Abbreviations and Acronyms DCB drug‐coated balloon DES drug‐eluting stent ISR in‐stent restenosis IVBT intravascular brachytherapy POBA plain old balloon angioplasty ST stent thrombosis TLR target lesion revascularization WSS wall shear stress New developments in percutaneous coronary intervention (PCI) technology, including the design of efficient guidewires, adjunctive PCI devices, and advances in stent technology, have simplified the procedure, reduced the risk of complications, increased procedural success, and improved long‐term outcomes, especially in high‐risk patients and complex lesions. Nevertheless, in selected patients and in challenging anatomies, the event rate remains high. 1 In‐stent restenosis (ISR) constitutes the most common cause of stent failure in the United States and United Kingdom, 2 , 3 and its management is challenging because reintervention is needed in 10.3% to 36.8% of the patients at 3‐year follow‐up. 4 , 5 Although the incidence of stent thrombosis (ST) has been considerably reduced after the introduction of the second‐generation drug eluting stents (DES) as shown in clinical trials, in clinical practice, the ST rates are higher and are associated with devastating consequences, because in such cases the clinical presentation is often death or myocardial infarction. 6 , 7 , 8 Over the past years, several endovascular therapies have been introduced to successfully treat ISR that were evaluated in numerous randomized control studies (Figure S1, Table S1). Despite the undoubted value of these studies in clinical practice, they all had a significant limitation: they did not use intravascular imaging to identify the underlying mechanisms of stent failure and assess neointima characteristics that are likely to affect clinical outcomes. Intravascular imaging studies have underscored the importance of correcting causes of stent failure and the role of neointima composition on vessel wall response after repeat revascularization. Consequently, the routine use of intravascular imaging has IIa/C indication in the European Society of Cardiology guidelines for detecting causes of stent failure and personalizing therapy. 9 This review aimed to provide a comprehensive overview in the field, discusses the potential value of intravascular imaging in identifying causes of ISR and ST, presents clinical outcomes from small‐scale studies assessing different interventional strategies in challenging scenarios, and proposes a treatment algorithm that relies on the information derived from intravascular imaging to effectively treat ISR and ST. UNDERLYING MECHANISMS OF IN‐STENT RESTENOSIS The introduction of DES and developments in stent polymers and drug kinetics have si -Abstract Truncated-

Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty

Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study

Prediction Of Restenosis By Ivus

Association Between Periprocedural Myocardial Injury and Neointimal Characteristics in Patients with In-Stent Restenosis: an Optical Coherence Tomography Study.

Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.

Clinical Outcomes of the Intraluminal Approach for Long Occlusive Femoropopliteal Lesions Assessed by Intravascular Ultrasound

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management

Peter B. Samuels Award. Restenosis after percutaneous transluminal angioplasty

Incidence of Restenosis Following Rapamycin or Paclitaxeleluting Stent in Coronary Stent Implantation

High-Resolution Vessel Wall MRI in Assessing Postoperative Restenosis of Intracranial Atherosclerotic Disease Before Drug-Coated Balloon Treatment: An Outcome Prediction Study

[Intravascular Ultrasound Assessment of Sirolimus-Eluting Stent Restenosis or Thrombosis after Stent Implantation].

[New methods of coronary imaging II. Intracoronary ultrasonography in clinical practice]

Multivariate analysis of post-stenting coronary restenosis

Application of intravascular ultrasound in analysis on influencing factors of prognosis in patients with different coronary artery in-stent restenosis

Incidence and predictors of restenosis following successful recanalization of non-acute internal carotid artery occlusion in 252 cases

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy

Quantitative baseline CT plaque characterization of unrevascularized non-culprit intermediate coronary stenosis predicts lesion volume progression and long-term prognosis: A serial CT follow-up study

An Intravascular Ultrasound Study of Cypher, Taxus, and Endeavor Stents on Relation Between Neointimal Proliferation and Residual Plaque Burden

Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials

Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis

Analysis of risk factors of restenosis after coronary stenting